Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Urology|December 1, 1995
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapyM S Soloway, P F Schellhammer, J A Smith, et al.
Child and Adolescent Psychiatric Clinics of North America|September 14, 2024
Justice-Involved Youth: Support for Community and Family InterventionsCourtney L McMickens, Nicole Jackson, Kamille Williams, et al.
The Prostate|October 3, 2001
Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activityA Rimler, Z Culig, G Levy-Rimler, et al.
The Journal of Urology|January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once dailyR Hartung, H Matzkin, A Alcaraz, et al.
Urology|October 1, 1985
Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer GroupW W Koontz, N M Heney, M S Soloway, et al.
The Journal of Urology|October 1, 1995
Quality of life: radical prostatectomy versus radiation therapy for prostate cancerA J Lim, A H Brandon, J Fiedler, et al.
European Urology|January 1, 1996
A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study GroupM S Soloway, P Schellhammer, R Sharifi, et al.
Behavioural Brain Research|August 3, 2020
Visuomotor control of walking in Parkinson's disease: Exploring possible links between conscious movement processing and freezing of gaitL E S Hardeman, E C Kal, W R Young, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1992
Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study GroupB R Cassileth, M S Soloway, N J Vogelzang, et al.
Urology|May 1, 1989
Patients' choice of treatment in stage D prostate cancerB R Cassileth, M S Soloway, N J Vogelzang, et al.
Pageof 32